亚辉龙：回复合作问询，25年前三季度营收净利双降

Core Viewpoint - The company announced that its collaboration with Brain-Computer Starlink has not yet obtained medical device registration certification, with revenue expected to be generated by 2026 at the earliest [1] Group 1: Collaboration and Investment - The collaboration focuses on non-invasive technology and is still in the early stages, with an estimated investment of around 30 million yuan [1] - The company plans to invest no more than 15 million yuan in Brain-Computer Starlink [1] Group 2: Financial Performance - For the first three quarters of 2025, the company's revenue was 1.287 billion yuan, a year-on-year decrease of 7.69% [1] - The net profit for the same period was 60.42 million yuan, down 72.36% year-on-year, primarily due to industry policies and losses from trading financial assets [1] Group 3: Stock Price Movement - On January 6, the company's stock price experienced unusual fluctuations, and an internal investigation revealed that the Deputy Director of the President's Office, Yao Lan, sold 200 shares on January 5, which was unrelated to insider information [1]